Organon & Co. Common Stock

Financials

Visão geral Relatórios Estatísticas Dividendos

Fluxo de caixa operacional 390 M75 M220 M264 M141 M225 M 850 M Fluxo de caixa de investimento -296 M-172 M-38 M-115 M-65 M386 M 168 M Fluxo de caixa de financiamento -82 M-75 M-223 M-76 M-187 M-38 M -524 M Fluxo de caixa livre 390 M75 M181 M149 M96 M188 M 614 M

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co. Common Stock

Notícias

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

Ação da Organon & Co atinge máxima de 52 semanas em US$ 13,44

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Ação da Organon & Co atinge máxima de 52 semanas em US$ 13,40

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

An April To Remember For Stocks

Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon fica abaixo das estimativas com queda de 9% na receita

Company News for Apr 28, 2026

Nasdaq Futures Slip as AI Concerns Resurface, FOMC Meeting and Earnings in Focus

Tech Earnings Optimism Powers Stocks Higher